|
G |
Abca8 |
ATP binding cassette subfamily A member 8 |
multiple interactions |
ISO |
Verapamil inhibits the reaction [ABCA8 protein results in increased uptake of estradiol-17 beta-glucuronide] |
CTD |
PMID:12379217 |
|
NCBI chr10:95,416,984...95,490,647
Ensembl chr10:94,917,520...94,990,988
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
multiple interactions increases activity decreases expression decreases activity increases expression increases transport affects response to substance |
ISO EXP |
[Endosulfan co-treated with Verapamil] inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]; [Endosulfan co-treated with Verapamil] results in decreased activity of ABCB1 protein; [phosalone co-treated with Verapamil] inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]; [phosalone co-treated with Verapamil] results in decreased activity of ABCB1 protein; [Verapamil binds to and results in decreased activity of ABCB1 protein] inhibits the reaction [sodium arsenite promotes the reaction [ABCB1 protein results in increased secretion of calcein AM]]; [Verapamil binds to and results in decreased activity of ABCB1 protein] which results in decreased export of Digoxin; [Verapamil binds to and results in decreased activity of ABCB1 protein] which results in decreased transport of N-cyano-1-((3,4-dimethoxyphenyl)methyl)-3,4-dihydro-6,7-dimethoxy-N'-octyl-2(1H)-isoquinoline-carboximidamide; [Verapamil co-treated with kaempferol] results in decreased expression of ABCB1 mRNA; [Verapamil co-treated with kaempferol] results in decreased expression of ABCB1 protein; [Verapamil results in decreased activity of ABCB1 protein] which results in decreased export of calcein AM; [Verapamil results in decreased activity of ABCB1 protein] which results in decreased export of Rhodamine 123; [Verapamil results in decreased activity of ABCB1 protein] which results in decreased export of Topotecan; [Verapamil results in decreased activity of ABCB1 protein] which results in decreased transport of benzoylaconine; [Verapamil results in decreased activity of ABCB1 protein] which results in decreased transport of benzoylhypaconine; [Verapamil results in decreased activity of ABCB1 protein] which results in decreased transport of benzoylmesaconine; [Verapamil results in decreased activity of ABCB1 protein] which results in decreased transport of Digoxin; [Verapamil results in decreased activity of ABCB1 protein] which results in decreased transport of hypaconitine; [Verapamil results in decreased activity of ABCB1 protein] which results in decreased transport of mesaconitine; [Verapamil results in decreased activity of ABCB1 protein] which results in increased susceptibility to Doxorubicin; [Verapamil results in decreased activity of ABCB1 protein] which results in increased susceptibility to Paclitaxel; [Verapamil results in decreased activity of ABCB1 protein] which results in increased uptake of fluorexon; Colchicine inhibits the reaction [Verapamil analog results in increased activity of ABCB1 protein mutant form]; Cyclosporine inhibits the reaction [Verapamil analog results in increased activity of ABCB1 protein mutant form]; Demecolcine inhibits the reaction [Verapamil analog results in increased activity of ABCB1 protein mutant form]; Diazinon promotes the reaction [Verapamil inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]]; Diazinon promotes the reaction [Verapamil results in decreased activity of ABCB1 protein]; Glycyrrhetinic Acid inhibits the reaction [Verapamil results in increased activity of ABCB1 protein]; propiconazole promotes the reaction [Verapamil inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]]; propiconazole promotes the reaction [Verapamil results in decreased activity of ABCB1 protein]; Verapamil affects the reaction [ABCB1 protein results in increased export of Tacrolimus]; Verapamil binds to and affects the activity of ABCB1 protein; Verapamil binds to and results in decreased activity of ABCB1 protein; Verapamil inhibits the reaction [5-Methoxypsoralen results in decreased activity of ABCB1 protein]; Verapamil inhibits the reaction [[5-Methoxypsoralen results in decreased activity of ABCB1 protein] which results in decreased export of and results in increased abundance of Daunorubicin]; Verapamil inhibits the reaction [[Methoxsalen results in decreased activity of ABCB1 protein] which results in decreased export of and results in increased abundance of Daunorubicin]; Verapamil inhibits the reaction [ABCB1 protein affects the transport of traumatic acid]; Verapamil inhibits the reaction [ABCB1 protein affects the uptake of Vinblastine]; Verapamil inhibits the reaction [ABCB1 protein results in decreased abundance of Quercetin]; Verapamil inhibits the reaction [ABCB1 protein results in decreased susceptibility to Doxorubicin]; Verapamil inhibits the reaction [ABCB1 protein results in decreased susceptibility to Paclitaxel]; Verapamil inhibits the reaction [ABCB1 protein results in decreased susceptibility to Vincristine]; Verapamil inhibits the reaction [ABCB1 protein results in decreased uptake of Doxorubicin]; Verapamil inhibits the reaction [ABCB1 protein results in increased export of calcein AM]; Verapamil inhibits the reaction [ABCB1 protein results in increased export of Doxorubicin]; Verapamil inhibits the reaction [ABCB1 protein results in increased export of Fluorescent Dyes]; Verapamil inhibits the reaction [ABCB1 protein results in increased export of fluorexon]; Verapamil inhibits the reaction [ABCB1 protein results in increased export of Rhodamine 123]; Verapamil inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]; Verapamil inhibits the reaction [ABCB1 protein results in increased transport of cyazofamid]; Verapamil inhibits the reaction [ABCB1 protein results in increased transport of Daunorubicin]; Verapamil inhibits the reaction [ABCB1 protein results in increased transport of Digoxin]; Verapamil inhibits the reaction [ABCB1 protein results in increased transport of Doxorubicin]; Verapamil inhibits the reaction [ABCB1 protein results in increased transport of huperzine A]; Verapamil inhibits the reaction [ABCB1 protein results in increased transport of N-cyano-1-((3,4-dimethoxyphenyl)methyl)-3,4-dihydro-6,7-dimethoxy-N'-octyl-2(1H)-isoquinoline-carboximidamide]; Verapamil inhibits the reaction [ABCB1 protein results in increased transport of Paclitaxel]; Verapamil inhibits the reaction [ABCB1 protein results in increased transport of quinidinium]; Verapamil inhibits the reaction [ABCB1 protein results in increased transport of Sulpiride]; Verapamil inhibits the reaction [ABCB1 protein results in increased transport of Vinblastine]; Verapamil inhibits the reaction [ABCB1 protein results in increased uptake of Digoxin]; Verapamil inhibits the reaction [Acetaminophen results in increased activity of ABCB1 protein]; Verapamil inhibits the reaction [Doxorubicin results in increased activity of ABCB1 protein]; Verapamil inhibits the reaction [Methoxsalen results in decreased activity of ABCB1 protein]; Verapamil inhibits the reaction [tangeretin results in increased activity of ABCB1 protein]; Verapamil inhibits the reaction [Verapamil analog results in increased activity of ABCB1 protein mutant form]; Verapamil promotes the reaction [ABCB1 protein mutant form binds to 8-azidoadenosine 5'-triphosphate]; Verapamil promotes the reaction [galangin results in increased activity of ABCB1 protein]; Verapamil promotes the reaction [kaempferol results in increased activity of ABCB1 protein]; Verapamil promotes the reaction [propiconazole inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]]; Verapamil promotes the reaction [propiconazole results in decreased activity of ABCB1 protein]; Verapamil promotes the reaction [Quercetin results in increased activity of ABCB1 protein]; Vinblastine inhibits the reaction [Verapamil analog results in increased activity of ABCB1 protein mutant form]; yu ping feng san inhibits the reaction [Verapamil results in increased activity of ABCB1 protein] Verapamil analog results in increased activity of ABCB1 protein mutant form; Verapamil results in increased activity of ABCB1 protein Verapamil results in decreased expression of ABCB1 protein Verapamil results in increased expression of ABCB1 mRNA [Verapamil results in decreased expression of ABCB1] promotes the reaction [Doxorubicin results in increased activity of CASP3 protein]; [Verapamil results in decreased expression of ABCB1] promotes the reaction [Doxorubicin results in increased activity of CASP7 protein]; Verapamil promotes the reaction [Vanadates results in decreased activity of ABCB1A protein] Verapamil results in decreased expression of ABCB1A mRNA [Verapamil results in decreased activity of ABCB1 protein] inhibits the reaction [P-glycoprotein inducer and activator TX5 results in increased export of Rhodamine 123]; Verapamil inhibits the reaction [ABCB1 results in decreased susceptibility to Cadmium Chloride] ABCB1 protein results in increased transport of Verapamil ABCB1A protein affects the susceptibility to Verapamil Verapamil results in decreased activity of ABCB1A protein Verapamil results in decreased activity of ABCB1 protein; Verapamil results in decreased activity of ABCB1A protein |
CTD |
PMID:2900677 PMID:7083125 PMID:7476894 PMID:8917702 PMID:10527640 PMID:10571255 PMID:10636889 PMID:10997946 PMID:11027628 PMID:11836167 PMID:11895100 PMID:11920757 PMID:12202523 PMID:12387747 PMID:12670938 PMID:12708479 PMID:12711602 PMID:15112361 PMID:15276086 PMID:15451006 PMID:15502009 PMID:15627040 PMID:15640379 PMID:15725475 PMID:15861398 PMID:16033948 PMID:16049968 PMID:16121039 PMID:16442095 PMID:16904803 PMID:16930294 PMID:16959878 PMID:17134887 PMID:17526808 PMID:17947497 PMID:17973928 PMID:18204840 PMID:18408562 PMID:18673531 PMID:19070657 PMID:19505989 PMID:19528478 PMID:19944135 PMID:20457140 PMID:21783720 PMID:22079615 PMID:22233293 PMID:23200901 PMID:23273999 PMID:23976943 PMID:24321342 PMID:24380838 PMID:24446304 PMID:25058526 PMID:25268938 PMID:25625052 PMID:26995013 PMID:28587984 PMID:28597291 PMID:28669723 PMID:29079042 PMID:29174985 PMID:29625142 PMID:30102254 PMID:30391378 PMID:31348918 PMID:31756430 PMID:32003934 PMID:32497533 PMID:33321149 PMID:34135758 PMID:34217736 PMID:35063459 PMID:35550413 PMID:35753429 PMID:37259354 PMID:37985955 PMID:38367674 PMID:39041788 More...
|
|
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcb1b |
ATP-binding cassette, sub-family B member 1B |
decreases activity affects response to substance |
EXP ISO |
Verapamil results in decreased activity of ABCB1B protein ABCB1B protein affects the susceptibility to Verapamil |
CTD |
PMID:12202523 PMID:15502009 |
|
NCBI chr 4:26,197,706...26,280,156
Ensembl chr 4:25,242,798...25,325,199
|
|
G |
Abcb4 |
ATP binding cassette subfamily B member 4 |
decreases activity decreases expression |
EXP ISO |
Verapamil results in decreased activity of ABCB4 protein Verapamil results in decreased expression of ABCB4 mRNA |
CTD |
PMID:12202523 PMID:28437613 PMID:28552422 |
|
NCBI chr 4:26,106,895...26,164,440
Ensembl chr 4:25,151,953...25,209,202
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
affects activity multiple interactions decreases activity |
ISO |
Verapamil affects the activity of ABCC1 protein Verapamil inhibits the reaction [ABCC1 protein affects the export of 5-carboxyfluorescein diacetate]; Verapamil inhibits the reaction [ABCC1 protein affects the export of Daunorubicin]; Verapamil inhibits the reaction [ABCC1 protein results in decreased susceptibility to Doxorubicin]; Verapamil inhibits the reaction [ABCC1 protein results in decreased susceptibility to Vincristine]; Verapamil inhibits the reaction [ABCC1 protein results in increased export of 2',7'-bis-(carboxypropyl)-5(6)-carboxyfluorescein]; Verapamil promotes the reaction [ABCC1 protein affects the export of Glutathione]; Verapamil promotes the reaction [ABCC1 protein affects the transport of Glutathione]; Verapamil promotes the reaction [ABCC1 protein results in increased uptake of Glutathione] Verapamil results in decreased activity of ABCC1 protein Verapamil inhibits the reaction [ABCC1 protein results in decreased susceptibility to Etoposide]; Verapamil inhibits the reaction [ABCC1 protein results in decreased uptake of Daunorubicin]; Verapamil inhibits the reaction [ABCC1 protein results in decreased uptake of Etoposide] |
CTD |
PMID:7954421 PMID:9334814 PMID:10856430 PMID:11278867 PMID:12485947 PMID:15044619 PMID:15451006 PMID:15498506 PMID:16101123 PMID:16636798 More...
|
|
NCBI chr10:1,022,041...1,162,431
Ensembl chr10:531,812...655,114
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
multiple interactions |
ISO |
Verapamil inhibits the reaction [ABCC2 protein affects the export of 5-carboxyfluorescein diacetate] |
CTD |
PMID:16636798 |
|
NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Abcc3 |
ATP binding cassette subfamily C member 3 |
multiple interactions |
ISO |
Verapamil inhibits the reaction [ABCC3 protein affects the export of 5-carboxyfluorescein diacetate] |
CTD |
PMID:16636798 |
|
NCBI chr10:79,793,571...79,839,528
Ensembl chr10:79,296,693...79,342,595
|
|
G |
Abcc6 |
ATP binding cassette subfamily C member 6 |
decreases activity |
ISO |
Verapamil results in decreased activity of ABCC6 protein |
CTD |
PMID:14667841 |
|
NCBI chr 1:105,583,681...105,637,895
Ensembl chr 1:96,447,251...96,501,464
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
multiple interactions |
EXP |
Verapamil inhibits the reaction [[Carbon Tetrachloride co-treated with lard co-treated with Ethanol] results in increased expression of ACTA2 protein] |
CTD |
PMID:17223571 |
|
NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Adra1a |
adrenoceptor alpha 1A |
multiple interactions affects binding |
ISO |
[Quinidine co-treated with Verapamil] inhibits the reaction [ADRA1A protein results in increased abundance of Inositol 1,4,5-Trisphosphate]; Verapamil inhibits the reaction [ADRA1A protein results in increased abundance of Inositol 1,4,5-Trisphosphate] Verapamil binds to ADRA1A protein |
CTD |
PMID:9570190 |
|
NCBI chr15:45,005,648...45,111,416
Ensembl chr15:40,832,534...40,927,500
|
|
G |
Adra1b |
adrenoceptor alpha 1B |
affects binding multiple interactions |
ISO |
Verapamil binds to ADRA1B protein [Quinidine co-treated with Verapamil] inhibits the reaction [ADRA1B protein results in increased abundance of Inositol 1,4,5-Trisphosphate]; Verapamil inhibits the reaction [ADRA1B protein results in increased abundance of Inositol 1,4,5-Trisphosphate] |
CTD |
PMID:9570190 |
|
NCBI chr10:28,756,461...28,874,831
Ensembl chr10:28,255,025...28,312,919
|
|
G |
Adra1d |
adrenoceptor alpha 1D |
multiple interactions affects binding |
ISO |
[Quinidine co-treated with Verapamil] inhibits the reaction [ADRA1D protein results in increased abundance of Inositol 1,4,5-Trisphosphate]; Verapamil inhibits the reaction [ADRA1D protein results in increased abundance of Inositol 1,4,5-Trisphosphate] Verapamil binds to ADRA1D protein |
CTD |
PMID:9570190 |
|
NCBI chr 3:139,246,333...139,262,331
Ensembl chr 3:118,793,346...118,809,354
|
|
G |
Adrb1 |
adrenoceptor beta 1 |
affects response to substance |
ISO |
ADRB1 protein polymorphism affects the susceptibility to Verapamil |
CTD |
PMID:22192668 |
|
NCBI chr 1:265,777,103...265,780,114
Ensembl chr 1:255,771,597...255,807,259
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions |
EXP |
Verapamil inhibits the reaction [Thioacetamide results in decreased expression of AKT1 mRNA] |
CTD |
PMID:30526075 |
|
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Aqp1 |
aquaporin 1 |
multiple interactions |
ISO |
Verapamil inhibits the reaction [cobaltous chloride results in increased expression of AQP1 protein] |
CTD |
PMID:22415096 |
|
NCBI chr 4:85,812,784...85,824,964
Ensembl chr 4:84,482,512...84,494,690
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression multiple interactions |
ISO |
Verapamil results in increased expression of BAX protein [Verapamil co-treated with Temozolomide] results in increased expression of BAX mRNA; Temozolomide promotes the reaction [Verapamil results in increased expression of BAX protein] |
CTD |
PMID:30003979 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions decreases expression |
ISO |
[Temozolomide co-treated with Verapamil] results in decreased expression of BCL2 mRNA; [Temozolomide co-treated with Verapamil] results in decreased expression of BCL2 protein; [Verapamil co-treated with gambogic acid] results in decreased expression of BCL2 protein Verapamil results in decreased expression of BCL2 mRNA; Verapamil results in decreased expression of BCL2 protein |
CTD |
PMID:24373880 PMID:30003979 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Cacna1c |
calcium voltage-gated channel subunit alpha1 C |
increases response to substance multiple interactions decreases expression |
ISO EXP |
CACNA1C gene polymorphism results in increased susceptibility to Verapamil Mevalonic Acid inhibits the reaction [Verapamil results in decreased expression of CACNA1C mRNA]; Mevalonic Acid inhibits the reaction [Verapamil results in decreased expression of CACNA1C protein] Verapamil results in decreased expression of CACNA1C mRNA; Verapamil results in decreased expression of CACNA1C protein Verapamil inhibits the reaction [Iron-Dextran Complex affects the expression of CACNA1C protein] |
CTD |
PMID:19791473 PMID:20031608 PMID:27095094 |
|
NCBI chr 4:153,431,169...154,051,932
Ensembl chr 4:151,764,138...152,379,648
|
|
G |
Cacna1f |
calcium voltage-gated channel subunit alpha1 F |
multiple interactions |
ISO |
Verapamil inhibits the reaction [CACNA1F protein results in increased transport of Barium] |
CTD |
PMID:14744918 |
|
NCBI chr X:17,539,992...17,568,308
Ensembl chr X:14,868,024...14,896,413
|
|
G |
Cacna1h |
calcium voltage-gated channel subunit alpha1 H |
multiple interactions decreases expression |
EXP |
Mevalonic Acid inhibits the reaction [Verapamil results in decreased expression of CACNA1H mRNA]; Mevalonic Acid inhibits the reaction [Verapamil results in decreased expression of CACNA1H protein] Verapamil results in decreased expression of CACNA1H mRNA; Verapamil results in decreased expression of CACNA1H protein |
CTD |
PMID:19791473 |
|
NCBI chr10:14,894,630...14,952,317
Ensembl chr10:14,390,113...14,448,376
|
|
G |
Calca |
calcitonin-related polypeptide alpha |
multiple interactions |
ISO |
Verapamil inhibits the reaction [[Ionomycin co-treated with Lipopolysaccharides] results in increased expression of CALCA protein]; Verapamil inhibits the reaction [Lipopolysaccharides results in increased expression of CALCA mRNA] |
CTD |
PMID:20682585 |
|
NCBI chr 1:178,312,636...178,317,588
Ensembl chr 1:168,878,214...168,883,105
|
|
G |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
multiple interactions |
EXP |
Verapamil inhibits the reaction [LIF protein results in increased activity of CAMK2A protein]; Verapamil inhibits the reaction [LIF protein results in increased phosphorylation of CAMK2A protein] |
CTD |
PMID:11073891 |
|
NCBI chr18:56,648,779...56,711,505
Ensembl chr18:54,378,784...54,438,994
|
|
G |
Camk4 |
calcium/calmodulin-dependent protein kinase IV |
multiple interactions |
EXP |
Verapamil inhibits the reaction [LIF protein results in increased activity of CAMK4 protein] |
CTD |
PMID:11073891 |
|
NCBI chr18:24,857,152...25,076,054
Ensembl chr18:24,585,269...24,802,487
|
|
G |
Casp1 |
caspase 1 |
multiple interactions |
ISO |
Verapamil inhibits the reaction [7-ketocholesterol results in increased activity of CASP1 protein]; Verapamil inhibits the reaction [Cholesterol analog results in increased activity of CASP1 protein] |
CTD |
PMID:28633109 |
|
NCBI chr 8:10,746,338...10,882,295
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Casp12 |
caspase 12 |
multiple interactions |
ISO |
[Verapamil co-treated with Ruthenium Red co-treated with 2-aminoethoxydiphenyl borate] inhibits the reaction [Trichlorfon results in increased cleavage of and results in increased activity of CASP12 protein] |
CTD |
PMID:19631781 |
|
NCBI chr 8:10,927,188...10,954,442
Ensembl chr 8:2,642,434...2,674,037
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases expression |
ISO EXP |
[Doxorubicin co-treated with Verapamil] results in increased activity of CASP3 protein; [Verapamil co-treated with gambogic acid] results in increased cleavage of and results in increased activity of CASP3 protein; [Verapamil co-treated with Ruthenium Red co-treated with 2-aminoethoxydiphenyl borate] inhibits the reaction [Trichlorfon results in increased cleavage of and results in increased activity of CASP3 protein]; Verapamil inhibits the reaction [Pilocarpine results in increased activity of CASP3 protein] [Verapamil results in decreased expression of ABCB1] promotes the reaction [Doxorubicin results in increased activity of CASP3 protein] Verapamil inhibits the reaction [Simvastatin results in increased activity of CASP3 protein] Verapamil results in increased expression of CASP3 mRNA |
CTD |
PMID:14527821 PMID:15861398 PMID:18358092 PMID:19631781 PMID:19815060 PMID:19927300 PMID:24373880 More...
|
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp7 |
caspase 7 |
multiple interactions |
ISO |
[Verapamil results in decreased expression of ABCB1] promotes the reaction [Doxorubicin results in increased activity of CASP7 protein] |
CTD |
PMID:15861398 |
|
NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp8 |
caspase 8 |
multiple interactions |
ISO |
[Verapamil co-treated with gambogic acid] results in increased cleavage of and results in increased activity of CASP8 protein |
CTD |
PMID:24373880 |
|
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
ISO |
[Verapamil co-treated with gambogic acid] results in increased cleavage of and results in increased activity of CASP9 protein |
CTD |
PMID:24373880 |
|
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cd44 |
CD44 molecule |
multiple interactions |
ISO |
Verapamil inhibits the reaction [Tetradecanoylphorbol Acetate promotes the reaction [CD44 protein binds to Hyaluronic Acid]]; Verapamil inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of CD44 protein] [Verapamil co-treated with kaempferol] results in decreased expression of CD44 mRNA; [Verapamil co-treated with kaempferol] results in decreased expression of CD44 protein |
CTD |
PMID:9929743 PMID:35063459 |
|
NCBI chr 3:109,610,824...109,699,776
Ensembl chr 3:89,157,058...89,244,620
|
|
G |
Cdh1 |
cadherin 1 |
multiple interactions |
ISO |
Verapamil inhibits the reaction [TGFB1 protein results in decreased expression of CDH1 mRNA]; Verapamil inhibits the reaction [TGFB1 protein results in decreased expression of CDH1 protein] |
CTD |
PMID:34217686 |
|
NCBI chr19:51,402,178...51,471,572
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Ciita |
class II, major histocompatibility complex, transactivator |
affects expression |
ISO |
Verapamil affects the expression of CIITA mRNA |
CTD |
PMID:25811541 |
|
NCBI chr10:5,646,854...5,694,393
Ensembl chr10:5,140,178...5,187,440
|
|
G |
Clu |
clusterin |
affects expression |
ISO |
Verapamil affects the expression of CLU protein |
CTD |
PMID:12388792 |
|
NCBI chr15:44,336,619...44,375,861
Ensembl chr15:40,174,617...40,200,315
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
multiple interactions |
ISO |
Verapamil inhibits the reaction [Iron-Dextran Complex results in increased expression of COL1A1 protein] Verapamil inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 mRNA]; Verapamil inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 protein] |
CTD |
PMID:27095094 PMID:34217686 |
|
NCBI chr10:80,380,458...80,397,461
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
multiple interactions |
ISO |
Verapamil inhibits the reaction [TGFB1 protein results in increased expression of COL3A1 mRNA]; Verapamil inhibits the reaction [TGFB1 protein results in increased expression of COL3A1 protein] |
CTD |
PMID:34217686 |
|
NCBI chr 9:54,866,646...54,902,578
Ensembl chr 9:47,374,593...47,410,547
|
|
G |
Csrp3 |
cysteine and glycine rich protein 3 |
decreases localization |
EXP |
Verapamil results in decreased localization of CSRP3 protein |
CTD |
PMID:19376126 |
|
NCBI chr 1:107,664,338...107,682,916
Ensembl chr 1:98,528,068...98,546,653
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
decreases activity |
ISO |
Verapamil results in decreased activity of CYP1A1 protein |
CTD |
PMID:18420780 |
|
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
decreases activity |
ISO |
Verapamil results in decreased activity of CYP1A2 protein |
CTD |
PMID:18420780 |
|
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
decreases activity |
ISO |
Verapamil results in decreased activity of CYP1B1 protein |
CTD |
PMID:18420780 |
|
NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp2a3 |
cytochrome P450, family 2, subfamily a, polypeptide 3 |
decreases activity |
ISO |
Verapamil results in decreased activity of CYP2A4 protein |
CTD |
PMID:18420780 |
|
NCBI chr 1:82,171,914...82,179,980
Ensembl chr 1:82,169,949...82,179,979
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
decreases activity |
ISO |
Verapamil results in decreased activity of CYP2B10 protein |
CTD |
PMID:18420780 |
|
NCBI chr 1:90,780,468...90,859,852
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
multiple interactions |
EXP |
Verapamil inhibits the reaction [Cyclosporine results in increased expression of CYP2C11 protein] |
CTD |
PMID:28899749 |
|
NCBI chr 1:246,175,216...246,211,445
Ensembl chr 1:236,762,842...236,799,066
|
|
G |
Cyp2c6 |
cytochrome P450, family 2, subfamily C, polypeptide 6 |
decreases activity |
ISO |
Verapamil results in decreased activity of CYP2C29 protein |
CTD |
PMID:18420780 |
|
NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:237,693,094...238,057,596
|
|
G |
Cyp2c79 |
cytochrome P450, family 2, subfamily c, polypeptide 79 |
multiple interactions decreases activity |
ISO |
torsemide inhibits the reaction [Verapamil results in decreased activity of CYP2C8 protein] |
CTD |
PMID:15304522 |
|
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
decreases activity |
ISO |
Verapamil results in decreased activity of CYP2D22 protein; Verapamil results in decreased activity of CYP2D6 protein |
CTD |
PMID:18420780 |
|
NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:113,881,618...113,891,759
|
|
G |
Cyp3a18 |
cytochrome P450, family 3, subfamily a, polypeptide 18 |
decreases expression |
EXP |
Verapamil results in decreased expression of CYP3A18 mRNA |
CTD |
PMID:17973928 |
|
NCBI chr12:13,994,312...14,044,185
Ensembl chr12:8,880,528...8,930,381
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
multiple interactions affects metabolic processing decreases activity |
ISO |
[Verapamil results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA; naringin inhibits the reaction [CYP3A4 protein affects the metabolism of Verapamil]; Verapamil inhibits the reaction [CYP3A4 protein results in increased chemical synthesis of 1-hydroxymethylmidazolam]; Verapamil inhibits the reaction [CYP3A4 protein results in increased chemical synthesis of 6 beta-hydroxytestosterone]; Verapamil inhibits the reaction [CYP3A4 protein results in increased metabolism of Midazolam]; Verapamil inhibits the reaction [CYP3A4 protein results in increased metabolism of Testosterone]; Verapamil inhibits the reaction [CYP3A4 protein results in increased oxidation of 7-benzyloxy-4-trifluoromethylcoumarin] Verapamil results in decreased activity of CYP3A4 protein |
CTD |
PMID:15286053 PMID:15689501 PMID:15692829 PMID:15860655 PMID:16013069 PMID:19299527 PMID:21915887 PMID:25455453 More...
|
|
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
decreases activity decreases expression |
ISO EXP |
Verapamil results in decreased activity of CYP3A5 protein Verapamil results in decreased expression of CYP3A9 mRNA |
CTD |
PMID:15689501 PMID:17973928 |
|
NCBI chr12:21,919,955...21,960,160
Ensembl chr12:16,806,207...16,846,422
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
multiple interactions |
ISO |
[Verapamil co-treated with gambogic acid] results in increased expression of DDIT3 protein |
CTD |
PMID:24373880 |
|
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Dnm1l |
dynamin 1-like |
increases phosphorylation multiple interactions |
ISO |
Verapamil results in increased phosphorylation of DNM1L protein Verapamil inhibits the reaction [bisphenol A affects the localization of DNM1L protein] |
CTD |
PMID:31830493 PMID:34023961 |
|
NCBI chr11:98,084,049...98,135,663
Ensembl chr11:84,581,216...84,631,482
|
|
G |
Drd1 |
dopamine receptor D1 |
multiple interactions |
ISO |
Verapamil inhibits the reaction [SCH 23390 binds to DRD1 protein] |
CTD |
PMID:9533112 |
|
NCBI chr17:10,545,488...10,550,029
Ensembl chr17:10,540,558...10,545,002
|
|
G |
Drd2 |
dopamine receptor D2 |
multiple interactions |
ISO |
Verapamil inhibits the reaction [Raclopride binds to DRD2 protein] |
CTD |
PMID:9533112 |
|
NCBI chr 8:58,605,403...58,669,339
Ensembl chr 8:49,708,927...49,772,875
|
|
G |
Edn1 |
endothelin 1 |
multiple interactions |
ISO |
Verapamil inhibits the reaction [EDN1 protein results in increased expression of NPPB mRNA]; Verapamil inhibits the reaction [EDN1 protein results in increased expression of NPPB protein] |
CTD |
PMID:28942281 |
|
NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Fn1 |
fibronectin 1 |
multiple interactions |
ISO |
Verapamil inhibits the reaction [TGFB1 protein results in increased expression of FN1 mRNA]; Verapamil inhibits the reaction [TGFB1 protein results in increased expression of FN1 protein] |
CTD |
PMID:34217686 |
|
NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
Verapamil results in increased expression of FOS mRNA |
CTD |
PMID:12730611 |
|
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Fth1 |
ferritin heavy chain 1 |
multiple interactions |
ISO |
Verapamil inhibits the reaction [Iron-Dextran Complex results in increased expression of FTH1 protein] |
CTD |
PMID:27095094 |
|
NCBI chr 1:216,052,037...216,054,325
Ensembl chr 1:206,627,103...206,725,424
|
|
G |
Gal |
galanin and GMAP prepropeptide |
affects expression |
ISO |
Verapamil affects the expression of GAL protein |
CTD |
PMID:12388792 |
|
NCBI chr 1:210,079,709...210,084,572
Ensembl chr 1:200,650,439...200,654,959
|
|
G |
Gap43 |
growth associated protein 43 |
affects expression |
ISO |
Verapamil affects the expression of GAP43 protein |
CTD |
PMID:12388792 |
|
NCBI chr11:71,882,131...71,975,799
Ensembl chr11:58,376,371...58,470,045
|
|
G |
Gc |
GC, vitamin D binding protein |
affects expression |
EXP |
Verapamil affects the expression of GC protein |
CTD |
PMID:23533533 |
|
NCBI chr14:18,916,255...18,951,670
Ensembl chr14:18,632,135...18,667,567
|
|
G |
Gfap |
glial fibrillary acidic protein |
multiple interactions increases expression |
EXP |
Verapamil inhibits the reaction [diphenylditelluride results in decreased phosphorylation of GFAP protein]; Verapamil inhibits the reaction [diphenylditelluride results in increased phosphorylation of GFAP protein] Verapamil results in increased expression of GFAP mRNA |
CTD |
PMID:21863293 PMID:21879721 PMID:22954530 |
|
NCBI chr10:88,352,987...88,361,661
Ensembl chr10:87,852,890...87,861,589
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions |
EXP |
Verapamil inhibits the reaction [Thioacetamide results in increased expression of GPT protein] |
CTD |
PMID:30526075 |
|
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gsn |
gelsolin |
affects expression |
EXP |
Verapamil affects the expression of GSN protein |
CTD |
PMID:23533533 |
|
NCBI chr 3:38,982,605...39,035,849
Ensembl chr 3:18,585,172...18,638,402
|
|
G |
Hamp |
hepcidin antimicrobial peptide |
multiple interactions |
ISO |
Verapamil promotes the reaction [Iron-Dextran Complex results in increased expression of HAMP mRNA] |
CTD |
PMID:27095094 |
|
NCBI chr 1:95,298,332...95,300,271
Ensembl chr 1:86,170,901...86,172,891
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression multiple interactions |
ISO EXP |
Verapamil results in increased expression of HMOX1 protein Verapamil inhibits the reaction [Thioacetamide results in decreased expression of HMOX1 mRNA] |
CTD |
PMID:21525764 PMID:30526075 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Iapp |
islet amyloid polypeptide |
multiple interactions |
EXP |
Verapamil inhibits the reaction [Glucose results in increased expression of IAPP mRNA] |
CTD |
PMID:9142872 |
|
NCBI chr 4:176,968,097...176,975,363
Ensembl chr 4:175,237,115...175,242,920
|
|
G |
Il1a |
interleukin 1 alpha |
multiple interactions |
ISO |
Verapamil inhibits the reaction [Particulate Matter results in increased expression of IL1A mRNA] |
CTD |
PMID:15613243 |
|
NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO EXP |
Verapamil inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA] Verapamil inhibits the reaction [Diethylhexyl Phthalate results in increased secretion of IL6 protein] |
CTD |
PMID:20682585 PMID:35460826 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Insr |
insulin receptor |
multiple interactions |
EXP |
Verapamil inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of INSR mRNA]; Verapamil inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of INSR protein] |
CTD |
PMID:35460826 |
|
NCBI chr12:5,991,135...6,129,275
Ensembl chr12:1,197,100...1,330,883
|
|
G |
Kcna10 |
potassium voltage-gated channel subfamily A member 10 |
multiple interactions |
ISO |
Verapamil inhibits the reaction [KCNA10 protein results in increased transport of Potassium] |
CTD |
PMID:10836990 |
|
NCBI chr 2:194,786,500...194,798,575
Ensembl chr 2:194,786,500...194,798,575
|
|
G |
Kcna3 |
potassium voltage-gated channel subfamily A member 3 |
decreases activity multiple interactions |
ISO |
Verapamil results in decreased activity of KCNA3 protein [Verapamil results in decreased activity of KCNA3 protein] which results in decreased import of Thallium |
CTD |
PMID:21362439 |
|
NCBI chr 2:197,320,324...197,322,277
Ensembl chr 2:194,632,196...194,650,138
|
|
G |
Kcnd3 |
potassium voltage-gated channel subfamily D member 3 |
decreases activity |
ISO |
Verapamil results in decreased activity of KCND3 protein |
CTD |
PMID:11181069 |
|
NCBI chr 2:195,626,316...195,843,690
Ensembl chr 2:192,937,950...193,155,345
|
|
G |
Kcnh2 |
potassium voltage-gated channel subfamily H member 2 |
multiple interactions decreases activity |
ISO |
[Verapamil results in decreased activity of KCNH2 protein] which results in decreased import of Thallium; Verapamil inhibits the reaction [KCNH2 protein results in increased transport of Thallium] |
CTD |
PMID:15671647 PMID:19583963 PMID:21158687 PMID:21362439 PMID:24052561 PMID:30561737 More...
|
|
NCBI chr 4:11,719,357...11,751,424
Ensembl chr 4:10,826,928...10,859,008
|
|
G |
Kcnmb1 |
potassium calcium-activated channel subfamily M regulatory beta subunit 1 |
affects response to substance |
ISO |
KCNMB1 gene SNP affects the susceptibility to Verapamil |
CTD |
PMID:17700361 |
|
NCBI chr10:19,062,014...19,119,005
Ensembl chr10:18,557,904...18,565,798
|
|
G |
Lif |
LIF, interleukin 6 family cytokine |
multiple interactions |
EXP |
Verapamil inhibits the reaction [LIF protein results in increased activity of CAMK2A protein]; Verapamil inhibits the reaction [LIF protein results in increased activity of CAMK4 protein]; Verapamil inhibits the reaction [LIF protein results in increased phosphorylation of CAMK2A protein] |
CTD |
PMID:11073891 |
|
NCBI chr14:83,354,602...83,364,053
Ensembl chr14:79,134,574...79,140,482
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
ISO |
Verapamil inhibits the reaction [tetrabromobisphenol A results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:15456914 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
ISO |
Verapamil inhibits the reaction [tetrabromobisphenol A results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:15456914 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions |
EXP |
Verapamil inhibits the reaction [Gentamicins results in increased phosphorylation of and results in increased activity of MAPK8 protein] |
CTD |
PMID:15936777 |
|
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mmp13 |
matrix metallopeptidase 13 |
multiple interactions |
EXP |
Verapamil promotes the reaction [ferrous sulfate results in increased expression of MMP13 protein] |
CTD |
PMID:27095094 |
|
NCBI chr 8:12,782,829...12,793,108
Ensembl chr 8:4,497,960...4,508,239
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions |
EXP |
Verapamil promotes the reaction [Paraquat results in increased activity of MPO protein] |
CTD |
PMID:17015168 |
|
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
multiple interactions |
EXP |
Verapamil inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of MTOR mRNA]; Verapamil inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of MTOR protein] |
CTD |
PMID:35460826 |
|
NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Mybpc3 |
myosin binding protein C3 |
affects response to substance |
ISO |
MYBPC3 protein affects the susceptibility to Verapamil |
CTD |
PMID:23896226 |
|
NCBI chr 3:97,550,974...97,569,216
Ensembl chr 3:77,095,252...77,113,405
|
|
G |
Myh7 |
myosin heavy chain 7 |
multiple interactions decreases expression |
ISO |
Dexamethasone inhibits the reaction [Verapamil results in decreased expression of MYH7 mRNA]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [Verapamil results in decreased expression of MYH7 mRNA]] |
CTD |
PMID:19596060 |
|
NCBI chr15:32,416,525...32,439,851
Ensembl chr15:28,446,550...28,468,217
|
|
G |
Myl2 |
myosin light chain 2 |
decreases expression multiple interactions |
ISO |
Verapamil results in decreased expression of MYL2 mRNA [Verapamil co-treated with Doxorubicin] results in decreased expression of MYL2 mRNA; Dexamethasone inhibits the reaction [[Verapamil co-treated with Doxorubicin] results in decreased expression of MYL2 mRNA]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [[Verapamil co-treated with Doxorubicin] results in decreased expression of MYL2 mRNA]] |
CTD |
PMID:19596060 |
|
NCBI chr12:40,114,964...40,126,236
Ensembl chr12:34,454,218...34,468,983
|
|
G |
Nanog |
Nanog homeobox |
multiple interactions |
ISO |
[Verapamil co-treated with kaempferol] results in decreased expression of NANOG mRNA; [Verapamil co-treated with kaempferol] results in decreased expression of NANOG protein |
CTD |
PMID:35063459 |
|
NCBI chr 4:157,615,687...157,623,061
Ensembl chr 4:155,943,737...155,951,116
|
|
G |
Nefl |
neurofilament light chain |
multiple interactions |
EXP |
Verapamil inhibits the reaction [diphenylditelluride results in decreased phosphorylation of NEFL protein]; Verapamil inhibits the reaction [diphenylditelluride results in increased phosphorylation of NEFL protein] |
CTD |
PMID:21863293 PMID:21879721 |
|
NCBI chr15:46,477,330...46,481,203
Ensembl chr15:42,301,916...42,305,793
|
|
G |
Nefm |
neurofilament medium chain |
multiple interactions |
EXP |
Verapamil inhibits the reaction [diphenylditelluride results in decreased phosphorylation of NEFM protein]; Verapamil inhibits the reaction [diphenylditelluride results in increased phosphorylation of NEFM protein] |
CTD |
PMID:21863293 PMID:21879721 |
|
NCBI chr15:46,535,857...46,541,161
Ensembl chr15:42,360,454...42,365,755
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
affects localization multiple interactions |
ISO EXP |
Verapamil affects the localization of NFE2L2 protein Verapamil inhibits the reaction [Thioacetamide results in decreased expression of NFE2L2 mRNA]; Verapamil inhibits the reaction [Thioacetamide results in decreased expression of NFE2L2 protein]; Verapamil promotes the reaction [Cilostazol inhibits the reaction [Thioacetamide results in decreased expression of NFE2L2 protein]] |
CTD |
PMID:21525764 PMID:30295103 PMID:30526075 |
|
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
multiple interactions |
EXP |
Verapamil inhibits the reaction [Diethylhexyl Phthalate results in increased expression of NLRP3 mRNA]; Verapamil inhibits the reaction [Diethylhexyl Phthalate results in increased expression of NLRP3 protein] |
CTD |
PMID:35460826 |
|
NCBI chr10:44,826,299...44,853,373
Ensembl chr10:44,328,566...44,352,811
|
|
G |
Nppa |
natriuretic peptide A |
multiple interactions affects secretion increases expression |
ISO |
[Cilazapril co-treated with Verapamil] affects the secretion of NPPA protein Verapamil affects the secretion of NPPA protein Verapamil results in increased expression of NPPA protein |
CTD |
PMID:1457087 PMID:11996326 |
|
NCBI chr 5:163,712,184...163,713,493
Ensembl chr 5:158,429,042...158,430,351
|
|
G |
Nppb |
natriuretic peptide B |
multiple interactions |
ISO |
Verapamil inhibits the reaction [EDN1 protein results in increased expression of NPPB mRNA]; Verapamil inhibits the reaction [EDN1 protein results in increased expression of NPPB protein] |
CTD |
PMID:28942281 |
|
NCBI chr 5:163,699,955...163,701,314
Ensembl chr 5:158,416,866...158,418,168
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions |
EXP |
Verapamil inhibits the reaction [Thioacetamide results in decreased expression of NQO1 protein]; Verapamil promotes the reaction [Cilostazol inhibits the reaction [Thioacetamide results in decreased expression of NQO1 protein]] |
CTD |
PMID:30295103 |
|
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nr0b1 |
nuclear receptor subfamily 0, group B, member 1 |
decreases expression multiple interactions |
ISO |
Verapamil results in decreased expression of NR0B1 mRNA Verapamil promotes the reaction [Cyclic AMP results in decreased expression of NR0B1 mRNA] |
CTD |
PMID:19822634 |
|
NCBI chr X:54,707,658...54,711,786
Ensembl chr X:50,756,886...50,761,011
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
increases activity multiple interactions |
ISO |
Verapamil results in increased activity of NR1I2 protein [Verapamil results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA |
CTD |
PMID:25455453 |
|
NCBI chr11:75,965,717...76,006,733
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
multiple interactions |
ISO |
Verapamil promotes the reaction [Dexamethasone results in increased activity of NR3C1 protein] |
CTD |
PMID:12871829 |
|
NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,271,681...31,393,375
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions |
ISO |
Verapamil inhibits the reaction [PARP1 gene mutant form results in decreased uptake of Doxorubicin] [Verapamil co-treated with gambogic acid] results in increased cleavage of PARP1 protein; Acetylcysteine inhibits the reaction [[Verapamil co-treated with gambogic acid] results in increased cleavage of PARP1 protein]; benzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [[Verapamil co-treated with gambogic acid] results in increased cleavage of PARP1 protein] |
CTD |
PMID:15861398 PMID:24373880 |
|
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pf4 |
platelet factor 4 |
decreases expression |
ISO |
Verapamil results in decreased expression of PF4 protein |
CTD |
PMID:2962587 |
|
NCBI chr14:17,582,477...17,583,392
Ensembl chr14:17,298,308...17,299,365
|
|
G |
Polr1h |
RNA polymerase I subunit H |
multiple interactions |
ISO |
Verapamil inhibits the reaction [POLR1H protein results in decreased susceptibility to Doxorubicin]; Verapamil inhibits the reaction [POLR1H protein results in decreased susceptibility to Etoposide]; Verapamil inhibits the reaction [POLR1H protein results in decreased susceptibility to Vincristine]; Verapamil inhibits the reaction [POLR1H protein results in increased secretion of Doxorubicin] |
CTD |
PMID:14726695 |
|
NCBI chr20:1,594,936...1,598,854
Ensembl chr20:1,594,936...1,598,854
|
|
G |
Pou5f1 |
POU class 5 homeobox 1 |
multiple interactions |
ISO |
[Verapamil co-treated with kaempferol] results in decreased expression of POU5F1 mRNA; [Verapamil co-treated with kaempferol] results in decreased expression of POU5F1 protein |
CTD |
PMID:35063459 |
|
NCBI chr20:3,227,836...3,232,598
Ensembl chr20:3,223,129...3,227,891
|
|
G |
Ppbp |
pro-platelet basic protein |
decreases expression |
ISO |
Verapamil results in decreased expression of PPBP protein |
CTD |
PMID:2962587 |
|
NCBI chr14:17,586,495...17,587,299
Ensembl chr14:17,302,326...17,303,130
|
|
G |
Ppp3cb |
protein phosphatase 3 catalytic subunit beta |
multiple interactions |
ISO |
Verapamil inhibits the reaction [bisphenol F results in increased expression of PPP3CB protein] |
CTD |
PMID:34023961 |
|
NCBI chr15:3,809,182...3,854,204
Ensembl chr15:3,760,030...3,804,981
|
|
G |
Prl |
prolactin |
multiple interactions increases expression increases secretion |
ISO |
Verapamil inhibits the reaction [Sulpiride results in increased secretion of PRL protein]; Verapamil promotes the reaction [TRH protein results in increased secretion of PRL protein] Verapamil results in increased expression of PRL protein Verapamil results in increased secretion of PRL protein |
CTD |
PMID:7851873 PMID:8845563 PMID:8977754 PMID:20595935 |
|
NCBI chr17:38,287,355...38,298,234
Ensembl chr17:37,860,007...37,870,062
|
|
G |
Ret |
ret proto-oncogene |
affects expression |
ISO |
Verapamil affects the expression of RET protein |
CTD |
PMID:12388792 |
|
NCBI chr 4:152,998,344...153,040,556
Ensembl chr 4:151,326,431...151,368,176
|
|
G |
Slc11a2 |
solute carrier family 11 member 2 |
multiple interactions |
ISO |
Verapamil inhibits the reaction [Iron-Dextran Complex results in increased expression of SLC11A2 protein] |
CTD |
PMID:27095094 |
|
NCBI chr 7:133,381,878...133,429,921
Ensembl chr 7:131,503,081...131,540,145
|
|
G |
Slc19a3 |
solute carrier family 19 member 3 |
multiple interactions |
ISO |
Verapamil inhibits the reaction [SLC19A3 protein results in increased uptake of Metformin]; Verapamil inhibits the reaction [SLC19A3 protein results in increased uptake of Thiamine] |
CTD |
PMID:26528626 |
|
NCBI chr 9:84,275,722...84,299,368
Ensembl chr 9:84,277,024...84,299,337
|
|
G |
Slc22a1 |
solute carrier family 22 member 1 |
multiple interactions |
ISO |
Verapamil inhibits the reaction [SLC22A1 protein results in increased import of Tetraethylammonium]; Verapamil inhibits the reaction [SLC22A1 protein results in increased transport of 1-Methyl-4-phenylpyridinium]; Verapamil inhibits the reaction [SLC22A1 protein results in increased uptake of 1-Methyl-4-phenylpyridinium]; Verapamil inhibits the reaction [SLC22A1 protein results in increased uptake of Tetraethylammonium] |
CTD |
PMID:21641380 PMID:25466967 PMID:25862123 PMID:27450509 PMID:27989701 |
|
NCBI chr 1:50,624,339...50,651,437
Ensembl chr 1:48,076,666...48,103,678
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
multiple interactions |
ISO EXP |
Verapamil inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] Verapamil inhibits the reaction [SLC22A2 protein results in increased uptake of mepiquat] |
CTD |
PMID:21599003 PMID:33639197 |
|
NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:48,121,061...48,163,268
|
|
G |
Slc22a3 |
solute carrier family 22 member 3 |
multiple interactions |
ISO |
Verapamil inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium]; Verapamil inhibits the reaction [SLC22A3 protein results in increased uptake of Metformin] |
CTD |
PMID:21641380 PMID:21697722 |
|
NCBI chr 1:50,783,218...50,872,358
Ensembl chr 1:48,235,476...48,324,612
|
|
G |
Slc22a4 |
solute carrier family 22 member 4 |
multiple interactions |
ISO |
Verapamil inhibits the reaction [SLC22A4 protein results in increased uptake of Tetraethylammonium] |
CTD |
PMID:21641380 |
|
NCBI chr10:38,634,098...38,687,409
Ensembl chr10:38,133,322...38,179,720
|
|
G |
Slc22a5 |
solute carrier family 22 member 5 |
decreases activity |
ISO |
Verapamil results in decreased activity of SLC22A5 protein |
CTD |
PMID:15486076 |
|
NCBI chr10:38,509,072...38,536,240
Ensembl chr10:38,008,311...38,035,309
|
|
G |
Slc2a4 |
solute carrier family 2 member 4 |
multiple interactions |
EXP |
Verapamil inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of SLC2A4 mRNA]; Verapamil inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of SLC2A4 protein] |
CTD |
PMID:35460826 |
|
NCBI chr10:55,164,721...55,170,289
Ensembl chr10:54,666,015...54,671,565
|
|
G |
Slc47a1 |
solute carrier family 47 member 1 |
multiple interactions decreases activity |
ISO |
Verapamil inhibits the reaction [SLC47A1 protein results in increased import of Tetraethylammonium]; Verapamil inhibits the reaction [SLC47A1 protein results in increased uptake of 1-Methyl-4-phenylpyridinium]; Verapamil inhibits the reaction [SLC47A1 protein results in increased uptake of Tetraethylammonium] Verapamil results in decreased activity of SLC47A1 protein |
CTD |
PMID:22419765 PMID:27450509 PMID:27989701 PMID:31364238 |
|
NCBI chr10:46,533,580...46,590,128
Ensembl chr10:46,034,122...46,087,637
|
|
G |
Slc47a2 |
solute carrier family 47 member 2 |
decreases activity multiple interactions |
ISO |
Verapamil results in decreased activity of SLC47A2 protein Verapamil inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium]; Verapamil inhibits the reaction [SLC47A2 protein results in increased uptake of Tetraethylammonium] |
CTD |
PMID:22419765 PMID:27989701 PMID:28629854 PMID:31364238 |
|
NCBI chr10:45,990,806...46,033,937
Ensembl chr10:45,991,095...46,033,904
|
|
G |
Slco1a4 |
solute carrier organic anion transporter family, member 1a4 |
multiple interactions |
ISO |
Verapamil inhibits the reaction [SLCO1A2 protein results in increased uptake of Quercetin] |
CTD |
PMID:24947867 |
|
NCBI chr 4:176,441,104...176,495,846
Ensembl chr 4:174,710,004...175,254,573
|
|
G |
Smad2 |
SMAD family member 2 |
multiple interactions |
ISO |
Verapamil inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD2 protein] |
CTD |
PMID:34217686 |
|
NCBI chr18:72,124,792...72,193,345
Ensembl chr18:69,850,377...69,912,323
|
|
G |
Sod1 |
superoxide dismutase 1 |
multiple interactions |
EXP |
[Verapamil co-treated with Cilostazol] inhibits the reaction [Thioacetamide results in decreased activity of SOD1 protein]; Verapamil inhibits the reaction [Dexamethasone inhibits the reaction [Paraquat results in increased activity of SOD1 protein]]; Verapamil inhibits the reaction [Thioacetamide results in decreased activity of SOD1 protein] |
CTD |
PMID:17015168 PMID:30295103 |
|
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sod2 |
superoxide dismutase 2 |
multiple interactions |
EXP |
Verapamil inhibits the reaction [Dexamethasone inhibits the reaction [Paraquat results in increased activity of SOD2 protein]] |
CTD |
PMID:17015168 |
|
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Sox2 |
SRY-box transcription factor 2 |
multiple interactions |
ISO |
[Verapamil co-treated with kaempferol] results in decreased expression of SOX2 mRNA |
CTD |
PMID:35063459 |
|
NCBI chr 2:119,465,131...119,467,542
Ensembl chr 2:117,536,929...117,539,338
|
|
G |
Star |
steroidogenic acute regulatory protein |
multiple interactions |
ISO |
[Cyclic AMP co-treated with Verapamil] results in increased expression of STAR protein; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [[Cyclic AMP co-treated with Verapamil] results in increased expression of STAR protein]; N-(2-(methylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [[Cyclic AMP co-treated with Verapamil] results in increased expression of STAR protein]; Verapamil promotes the reaction [Cyclic AMP results in increased expression of STAR mRNA]; Verapamil promotes the reaction [Cyclic AMP results in increased expression of STAR protein] |
CTD |
PMID:19822634 |
|
NCBI chr16:72,969,824...72,974,447
Ensembl chr16:66,264,807...66,271,672
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
multiple interactions |
EXP |
Verapamil inhibits the reaction [Isoproterenol results in increased phosphorylation of and results in increased expression of STAT3 protein]; Verapamil inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased expression of STAT3 protein] |
CTD |
PMID:19299911 |
|
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions |
EXP ISO |
Verapamil inhibits the reaction [[Carbon Tetrachloride co-treated with lard co-treated with Ethanol] results in increased expression of TGFB1 protein] Verapamil inhibits the reaction [TGFB1 protein results in decreased expression of CDH1 mRNA]; Verapamil inhibits the reaction [TGFB1 protein results in decreased expression of CDH1 protein]; Verapamil inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 mRNA]; Verapamil inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 protein]; Verapamil inhibits the reaction [TGFB1 protein results in increased expression of COL3A1 mRNA]; Verapamil inhibits the reaction [TGFB1 protein results in increased expression of COL3A1 protein]; Verapamil inhibits the reaction [TGFB1 protein results in increased expression of FN1 mRNA]; Verapamil inhibits the reaction [TGFB1 protein results in increased expression of FN1 protein]; Verapamil inhibits the reaction [TGFB1 protein results in increased expression of VIM protein]; Verapamil inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD2 protein] |
CTD |
PMID:17223571 PMID:34217686 |
|
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
affects expression multiple interactions |
ISO EXP |
Verapamil affects the expression of TIMP1 protein Verapamil inhibits the reaction [ferrous sulfate results in increased expression of TIMP1 protein] |
CTD |
PMID:12388792 PMID:27095094 |
|
NCBI chr X:3,766,509...3,772,578
Ensembl chr X:1,212,972...1,217,664
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO EXP |
Verapamil affects the reaction [Lipopolysaccharides results in increased secretion of TNF protein]; Verapamil inhibits the reaction [Particulate Matter results in increased secretion of TNF protein] Verapamil inhibits the reaction [tert-Butylhydroperoxide results in increased secretion of TNF protein] Verapamil inhibits the reaction [Diethylhexyl Phthalate results in increased secretion of TNF protein] |
CTD |
PMID:15613243 PMID:17092623 PMID:17129690 PMID:17369293 PMID:35460826 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Trh |
thyrotropin releasing hormone |
multiple interactions |
ISO |
Verapamil inhibits the reaction [TRH protein results in increased secretion of TSHB protein]; Verapamil promotes the reaction [TRH protein results in increased secretion of PRL protein] |
CTD |
PMID:7851873 |
|
NCBI chr 4:126,299,236...126,301,762
Ensembl chr 4:124,742,111...124,744,637
|
|
G |
Tshb |
thyroid stimulating hormone subunit beta |
multiple interactions |
ISO |
Verapamil inhibits the reaction [TRH protein results in increased secretion of TSHB protein] |
CTD |
PMID:7851873 |
|
NCBI chr 2:192,913,171...192,918,054
Ensembl chr 2:190,224,676...190,229,559
|
|
G |
Txnip |
thioredoxin interacting protein |
multiple interactions |
EXP |
Verapamil inhibits the reaction [Diethylhexyl Phthalate results in increased expression of TXNIP mRNA]; Verapamil inhibits the reaction [Diethylhexyl Phthalate results in increased expression of TXNIP protein] |
CTD |
PMID:35460826 |
|
NCBI chr 2:186,781,933...186,785,736
Ensembl chr 2:184,092,991...184,096,886
|
|
G |
Vim |
vimentin |
multiple interactions |
EXP ISO |
Verapamil inhibits the reaction [diphenylditelluride results in decreased phosphorylation of VIM protein]; Verapamil inhibits the reaction [diphenylditelluride results in increased phosphorylation of VIM protein] Verapamil inhibits the reaction [TGFB1 protein results in increased expression of VIM protein] |
CTD |
PMID:21863293 PMID:21879721 PMID:34217686 |
|
NCBI chr17:81,577,261...81,585,746
Ensembl chr17:76,668,647...76,677,187
|
|